Trial · NCT01925209
Results by group24
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 24
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in 6 Minute Walking Distance (6MWD) Test at Week 52 | BYM338/Bimagrumab 10 mg/kg | 8.63 | Standard Error 10.934 | meters | |
| Change From Baseline in 6 Minute Walking Distance (6MWD) Test at Week 52 | BYM338/Bimagrumab 3 mg/kg | 9.63 | Standard Error 10.770 | meters | |
| Change From Baseline in 6 Minute Walking Distance (6MWD) Test at Week 52 | BYM338/Bimagrumab 1 mg/kg | -10.27 | Standard Error 10.718 | meters | |
| Change From Baseline in 6 Minute Walking Distance (6MWD) Test at Week 52 | Placebo | -8.96 | Standard Error 10.765 | meters | |
| Estimated Within Treatment Group Lean Body Mass (LBM) Ratio at Week 52 | BYM338/Bimagrumab 10 mg/kg | 102.8 | 95% Confidence Interval 101.4 to 104.2 | Percentage | |
| Estimated Within Treatment Group Lean Body Mass (LBM) Ratio at Week 52 | BYM338/Bimagrumab 3 mg/kg | 100.4 | 95% Confidence Interval 99.1 to 101.8 | Percentage | |
| Estimated Within Treatment Group Lean Body Mass (LBM) Ratio at Week 52 | BYM338/Bimagrumab 1 mg/kg | 98.3 | 95% Confidence Interval 97.0 to 99.6 | Percentage | |
| Estimated Within Treatment Group Lean Body Mass (LBM) Ratio at Week 52 | Placebo | 97.2 | 95% Confidence Interval 95.9 to 98.5 | Percentage | |
| Change From Baseline in Quadriceps Quantitative Muscle Testing (QMT) on the Right Side at Week 52 | BYM338/Bimagrumab 10 mg/kg | -12.44 | Standard Error 6.021 | newtons | |
| Change From Baseline in Quadriceps Quantitative Muscle Testing (QMT) on the Right Side at Week 52 | BYM338/Bimagrumab 3 mg/kg | -20.36 | Standard Error 5.843 | newtons | |
| Change From Baseline in Quadriceps Quantitative Muscle Testing (QMT) on the Right Side at Week 52 | BYM338/Bimagrumab 1 mg/kg | -14.89 | Standard Error 5.828 | newtons | |
| Change From Baseline in Quadriceps Quantitative Muscle Testing (QMT) on the Right Side at Week 52 | Placebo | -16.48 | Standard Error 5.830 | newtons | |
| Change From Baseline in Sporadic Inclusion Body Myositis (sIBM) Functional Assessment (sIFA) Score at Week 52 | BYM338/Bimagrumab 10 mg/kg | 1.74 | Standard Error 1.915 | score on a scale | |
| Change From Baseline in Sporadic Inclusion Body Myositis (sIBM) Functional Assessment (sIFA) Score at Week 52 | BYM338/Bimagrumab 3 mg/kg | 3.56 | Standard Error 1.876 | score on a scale | |
| Change From Baseline in Sporadic Inclusion Body Myositis (sIBM) Functional Assessment (sIFA) Score at Week 52 | BYM338/Bimagrumab 1 mg/kg | 6.12 | Standard Error 1.899 | score on a scale | |
| Change From Baseline in Sporadic Inclusion Body Myositis (sIBM) Functional Assessment (sIFA) Score at Week 52 | Placebo | 6.85 | Standard Error 1.895 | score on a scale | |
| Estimated Annual Number of Falls Per Patient Within Treatment Group | BYM338/Bimagrumab 10 mg/kg | 4.33 | Annual number of falls per participant | ||
| Estimated Annual Number of Falls Per Patient Within Treatment Group | BYM338/Bimagrumab 3 mg/kg | 4.02 | Annual number of falls per participant | ||
| Estimated Annual Number of Falls Per Patient Within Treatment Group | BYM338/Bimagrumab 1 mg/kg | 4.70 | Annual number of falls per participant | ||
| Estimated Annual Number of Falls Per Patient Within Treatment Group | Placebo | 5.13 | Annual number of falls per participant |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01925209/results